Literature DB >> 22395890

Anti-retinal antibodies in serum of laser-treated rabbits.

Sarah E Scott1, Rachida A Bouhenni, Anthony M Chomyk, Jeffrey J Dunmire, Jayaprakash Patil, Hiroshi Nakamura, P Edward Deepak.   

Abstract

PURPOSE: Retinal injuries that affect the photoreceptors and/or the retinal pigment epithelium (RPE) may result in the leakage of retinal proteins into the systemic circulation. This study was designed to determine whether an immune response is elicited after an acute retinal injury resulting in circulating anti-retinal antibodies in the serum.
METHODS: Fifty laser burns of different grades (minimally visible lesion [MVL], grade II [GII], or grade III [GIII] lesions) were created in the retinas of Dutch Belted rabbits. The degree of laser burns was confirmed by fundus imaging and histology. Serum samples were collected from the animals 3 months after the retinal injury. Candidate autoantigens were identified by two-dimensional (2-D) Western blots of rabbit retinal lysate probed with sera from either control or laser-treated animals. Candidate autoantigens were further characterized by immunostaining to confirm their retinal localization.
RESULTS: Seven and 11 protein spots were selected from the MVL and GII laser-treated samples, respectively, for autoantigen identification. No protein spots were detected in the GIII laser-treated samples. Four candidate autoantigens were common to both MVL and GII lesions: dihydropyrimidinase-related protein 2, fructose-bisphosphate aldolase C, chaperonin-containing T-complex polypeptide 1 subunit zeta, and pyruvate kinase isozyme.
CONCLUSIONS: Laser-induced retinal injuries resulted in circulating anti-retinal antibodies that were detectable 3 months after the injury. The response appeared to vary with the severity of the laser retinal damage. The identification of the candidate antigens in this study suggest that this approach may permit future development of new diagnostic methods for retinal injuries.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395890     DOI: 10.1167/iovs.11-7685

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  Generating Recombinant Antibodies against Putative Biomarkers of Retinal Injury.

Authors:  Michael R Kierny; Thomas D Cunningham; Rachida A Bouhenni; Deepak P Edward; Brian K Kay
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

Review 2.  Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?

Authors:  Serge Camelo
Journal:  Autoimmune Dis       Date:  2014-04-30

Review 3.  Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers.

Authors:  Cynthia Yu-Wai-Man; Peng Tee Khaw
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-09-01       Impact factor: 4.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.